Cargando…

Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2

Epidemiological and mechanistic studies suggest that some US Food and Drug Administration (FDA)-approved drugs can reduce the incidence of cancer and inhibit tumor growth. Therefore, investigating FDA-approved drugs for cancer chemoprevention is a promising strategy. In this study, we screened FDA-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lili, Zhang, Yuhan, Li, Ang, Lu, Xuebo, Li, Mingzhu, Yuan, Qiang, Yang, Ning, Zhao, Xiaokun, Li, Xin, Jiang, Yanan, Liu, Kangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574346/ https://www.ncbi.nlm.nih.gov/pubmed/36284716 http://dx.doi.org/10.1016/j.omto.2022.09.007

Ejemplares similares

Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation
por: Li, Bo, et al.
Publicado: (2021)

Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2
por: Wang, Zitong, et al.
Publicado: (2022)

Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
por: Liu, Xinning, et al.
Publicado: (2023)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
por: Bao, Zhuo, et al.
Publicado: (2022)

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
por: Li, Mingzhu, et al.
Publicado: (2023)

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
por: Yang, Ning, et al.
Publicado: (2022)

Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021)

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
por: Qian, Haili
Publicado: (2022)

Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp
por: Wang, Zhuang, et al.
Publicado: (2022)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
por: Kain, Vasundhara, et al.
Publicado: (2010)

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
por: Chen, Bi-Lian, et al.
Publicado: (2015)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway
por: Wu, Wenjie, et al.
Publicado: (2023)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
por: Yin, Shuying, et al.
Publicado: (2020)

(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
por: Song, Mengqiu, et al.
Publicado: (2019)

Comparison of the physical and thermodynamic stability of amorphous azelnidipine and its coamorphous phase with piperazine
por: Du, Shuang, et al.
Publicado: (2018)

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
por: Xie, Yifei, et al.
Publicado: (2020)

Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma
por: Yuan, Qiang, et al.
Publicado: (2019)

Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation
por: Zhao, Simin, et al.
Publicado: (2019)

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
por: Liu, Xuejiao, et al.
Publicado: (2023)

Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
por: Tawaramoto, Kazuhito, et al.
Publicado: (2015)

Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020)

TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
por: Shi, Hui, et al.
Publicado: (2021)

A case of complete atrioventricular block with extremely high blood concentration of azelnidipine
por: Ide, Naohito, et al.
Publicado: (2021)

Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
por: Yang, Yi, et al.
Publicado: (2017)

Azelnidipine Inhibits Cultured Rat Aortic Smooth Muscle Cell Death Induced by Cyclic Mechanical Stretch
por: Zhao, Jing, et al.
Publicado: (2014)

Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma
por: Zheng, Zhen-Yuan, et al.
Publicado: (2022)

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020)

A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
por: Zhang, Dengfeng, et al.
Publicado: (2023)

Overexpression of LRIG1 regulates PTEN via MAPK/MEK signaling pathway in esophageal squamous cell carcinoma
por: Jiang, Xiaofang, et al.
Publicado: (2016)

MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma in vivo and in vitro via the MEK1-mediated ERK-MMP signaling pathway
por: Wang, Mingbo, et al.
Publicado: (2022)

Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2016)

Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats
por: Fakharaldeen, Zainab, et al.
Publicado: (2022)

Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
por: Zhao, Yong-Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4vufd169qim6gcg2u2bml4q2l